A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The study was carried out as a randomised, single-blind, active-controlled, multi-centric, phase III study with two parallel treatment groups. The primary efficacy criterion was the frequency of effective gut cleansing in each of the two treatment groups (grade A or B \"overall quality of gut cleansing\" as judged by a blinded expert panel on the basis of videotapes recorded during the endoscopic procedure).
Epistemonikos ID: 2d0a65dc9231805964ffee31865acdf0da56e0de
First added on: May 04, 2024